Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Miguel Mínguez"'
Autor:
Margalida Calafat, Paola Torres, Joan Tosca-Cuquerella, Rubén Sánchez-Aldehuelo, Montserrat Rivero, Marisa Iborra, María González-Vivo, Isabel Vera, Luisa de Castro, Luis Bujanda, Manuel Barreiro-de Acosta, Carlos González-Muñoza, Xavier Calvet, José Manuel Benítez, Mónica Llorente-Barrio, Gerard Surís, Fiorella Cañete, Lara Arias-García, David Monfort, Andrés Castaño-García, Francisco Javier Garcia-Alonso, José M. Huguet, Ignacio Marín-Jímenez, Rufo Lorente, Albert Martín-Cardona, Juan Ángel Ferrer, Patricia Camo, Javier P. Gisbert, Ramón Pajares, Fernando Gomollón, Jesús Castro-Poceiro, Jair Morales-Alvarado, Jordina Llaó, Andrés Rodríguez, Cristina Rodríguez, Pablo Pérez-Galindo, Mercè Navarro, Nuria Jiménez-García, Marta Carrillo-Palau, Isabel Blázquez-Gómez, Eva Sesé, Pedro Almela, Patricia Ramírez de la Piscina, Carlos Taxonera, Iago Rodríguez-Lago, Lidia Cabrinety, Milagros Vela, Miguel Mínguez, Francisco Mesonero, María José García, Mariam Aguas, Lucía Márquez, Marisol Silva Porto, Juan R. Pineda, Koldo García-Etxebarría, Federico Bertoletti, Eduard Brunet, Míriam Mañosa, Eugeni Domènech
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 17 (2024)
Background: Infliximab seems to be the most efficacious of the three available anti-TNF agents for ulcerative colitis (UC) but little is known when it is used as the second anti-TNF. Objectives: To compare the clinical and treatment outcomes of a sec
Externí odkaz:
https://doaj.org/article/775611ead93843fdbf2cc167c6af141b
Autor:
Vicente Pla-Martí, Jose Martín-Arévalo, Rosa Martí-Fernández, David Moro-Valdezate, Stephanie García-Botello, Alejandro Espí-Macías, Miguel Mínguez-Pérez, Maria Dolores Ruiz-Carmona, Jose Vicente Roig-Vila
Publikováno v:
Annals of Coloproctology, Vol 38, Iss 1, Pp 13-19 (2022)
Purpose This study was performed to evaluate the long-term evolution of continence and patient’s quality of life after surgical treatment for obstetric fecal incontinence. Methods A prospective longitudinal study was conducted including consecutive
Externí odkaz:
https://doaj.org/article/5356c089adbd45559de187b7215dc3d8
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 110, Iss 12, Pp 794-805 (2018)
RESUMEN Los trastornos motores y funcionales anorrectales son frecuentes en la población general. La manometría anorrectal permite estudiar la actividad motora anorrectal en reposo y simulando diferentes situaciones fisiológicas. La manometría an
Externí odkaz:
https://doaj.org/article/1b1f84fec8824e958ffbd865aafc30f1
Autor:
Joan, Tosca, Ana, Sánchez, Ana, Sanahuja, Rosana, Villagrasa, Paloma, Poyatos, Pilar, Mas, Isabel, Pascual, Paloma, Lluch, Belén, Herreros, Andrés, Peña, Vicente, Sánchiz, Miguel, Mínguez
Publikováno v:
American Journal of Gastroenterology. 117:1593-1604
Caustic ingestion management could be improved with a diagnostic approach based on risk factors. This study aimed to develop an algorithm derived from predictive factors of a poor clinical course, to evaluate its diagnostic accuracy and resource cons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e720f5701997ccf799de6b270b31129d
https://doi.org/10.14309/ajg.0000000000001953
https://doi.org/10.14309/ajg.0000000000001953
Autor:
Blanca Serrano-Falcón, Sílvia Delgado-Aros, Fermín Mearin, Constanza Ciriza de los Ríos, Jordi Serra, Miguel Mínguez, Miguel Montoro Huguet, Antonia Perelló, Cecilio Santander, Ángeles Pérez Aisa, Inmaculada Bañón-Rodríguez, Enrique Rey
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 12 (2019)
Background: Linaclotide is approved for the treatment of moderate-to-severe irritable bowel syndrome (IBS) with constipation (IBS-C) in adults. This study aimed to assess factors predictive of a clinical response and improvements in non-IBS symptoms
Externí odkaz:
https://doaj.org/article/50aafbf1ceab4e1c9ec2b632cf36f5b7
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 107, Iss 3, Pp 137-142 (2015)
Background: Infliximab, an anti-tumour necrosis factor approved for treatment of Crohn's disease and ulcerative colitis, is administered at predefined interdose-intervals. On insufficient response or loss of response, treatment can be intensified. Th
Externí odkaz:
https://doaj.org/article/44b7425ab7f14f6593b26781160eacac
Autor:
María Rocío Davis González, María Pilar Ballester, Eva Romero-González, Ana María Sánchez-Pardo, David Marti-Aguado, Joan Tosca, Carles Suria, Rosario Antón Ausejo, Isabel Pascual Moreno, María Dolores Planelles Silvestre, Miguel Mínguez Pérez, Marta Maia Bosca-Watts
Publikováno v:
Gastroenterologia y hepatologia.
Loss-of-response and adverse events (AE) to biologics have been linked to HLA-DQA1*05 allele. However, the clinical factors or biologic used may influence treatment duration. Our objective was to evaluate the influence of clinical and therapeutic fac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39cb14609d77a191ff4903b0817ead58
https://pubmed.ncbi.nlm.nih.gov/36375696
https://pubmed.ncbi.nlm.nih.gov/36375696
Autor:
Silvio Danese, Severine Vermeire, Geert D'Haens, Julian Panés, Axel Dignass, Fernando Magro, Maciej Nazar, Manuela Le Bars, Marjolein Lahaye, Lioudmila Ni, Ivana Bravata, Frederic Lavie, Marco Daperno, Milan Lukáš, Alessandro Armuzzi, Mark Löwenberg, Daniel R Gaya, Laurent Peyrin-Biroulet, Rodolfo Rocca, Susana Lopes, Flavio Caprioli, Sandro Ardizzone, Ana Echarri Piudo, Paolo Gionchetti, Xavier Roblin, Ursula Seidler, David Andersson, Kamal Patel, Pierre Desreumaux, Simone Saibeni, Gustav From, Miroslav Fedurco, Milos Gregus, Yoram Bouhnik, Andreas Luegering, Rocco Cosintino, Ivan Bunganic, Jaime Ramos, Mariam Aguas Peris, Olivier Dewit, Mariabeatrice Principi, Emma Wesley, Paula Lago, Stephane Nancey, María Dolores Martín Arranz, Pieter Hindryckx, Ambrogio Orlando, Andrea Geccherle, Maria Laura Annunziata, Bu'hussain Hayee, Jozef Balaz, Francisco Portela, Cyrielle Gilletta, Torsten Kucharzik, Miguel Mínguez, Javier Pérez Gisbert, Ana Gutiérrez Casbas, Edouard Louis, Marco Marino, Gareth Parkes, Fraser Cummings, Bindia Jharap, Jens Kjeldsen, Luís Correia, Paula Ministro, Matthias Ebert, Erik Hertervig, Dirk Staessen, Joris Dutré, Arnaud Colard, Graham Morrison, Henning Glerup, Jens Frederik Dahlerup, Frank Wolfhagen, Marian Batovsky, Martin Molnar, Barbora Kadleckova, Paulo Caldeira, David Laharie, Xavier Hebuterne, Bruno Bonaz, Matthieu Allez, Andreas Fischer, Joaquín Ernesto Hinojosa Del Val, Miriam Mañosa Ciria, Jose Manuel Herrera Justiniano, Charlotte Soderman, Rajiv Chandy, Craig Mowat, Peter Irving, Jan Fallingborg, Jan Matous, Tomas Douda, Romain Altwegg, Jose Manuel Benitez, María Teresa Arroyo Villarino, Jordi Guardiola Capón, Daniel Ginard Vicenc, Pieter Dewint, Sven Almer, Sebastien Kindt
Publikováno v:
Danese, S, Vermeire, S, D'Haens, G, Panés, J, Dignass, A, Magro, F, Nazar, M, Le Bars, M, Lahaye, M, Ni, L, Bravata, I, Lavie, F, Daperno, M, Lukáš, M, Armuzzi, A, Löwenberg, M, Gaya, D R, Peyrin-Biroulet, L & STARDUST study group 2022, ' Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST) : an open-label, multicentre, randomised phase 3b trial ', The Lancet Gastroenterology and Hepatology, vol. 7, no. 4, pp. 294-306 . https://doi.org/10.1016/S2468-1253(21)00474-X
lancet. Gastroenterology & hepatology, 7(4), 294-306. Elsevier Limited
The Lancet Gastroenterology and Hepatology, 7(4), 294-306. Elsevier Ltd
lancet. Gastroenterology & hepatology, 7(4), 294-306. Elsevier Limited
The Lancet Gastroenterology and Hepatology, 7(4), 294-306. Elsevier Ltd
Background: A treat-to-target strategy, in which strictly defined treatment targets facilitate decision making in clinical practice, is advocated as an optimised management approach for some chronic disorders. The aim of the STARDUST trial was to ass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c41ea76bc7f88c535499cddcf9ba8ad
https://pure.au.dk/portal/da/publications/treat-to-target-versus-standard-of-care-for-patients-with-crohns-disease-treated-with-ustekinumab-stardust(6e02a521-a146-4afb-857c-d91bbe745a10).html
https://pure.au.dk/portal/da/publications/treat-to-target-versus-standard-of-care-for-patients-with-crohns-disease-treated-with-ustekinumab-stardust(6e02a521-a146-4afb-857c-d91bbe745a10).html
Autor:
María Chaparro, María García Donday, Saioa Rubio, Cristina Calviño Suarez, Andrea Núñez Ortiz, Montserrat Figueira, Sandra Marín Pedrosa, Montserrat Rivero, Agnes Fernández-Clotet, Lucía Madero, María Teresa Diz-Lois Palomares, Isabel Pérez-Martínez, Alexandra Ruiz-Cerulla, Maite Arroyo, Marta Piqueras, Cristina Suárez Ferrer, Mariam Aguas, Marta Calvo Moya, Iván Guerra, Pilar López Serrano, Juan María Vázquez Morón, Lara Arias García, María José Casanova, José María Huguet, Gemma Valldosera Gomis, Beatriz Zúñiga de Mora-Figueroa, Rubén Armesto, Pilar Martínez Montiel, Iago Rodríguez-Lago, Pau Sendra Rumbeu, Raquel Camargo Camero, Daniel Hervías Cruz, Gema Molina Arriero, Carlos Tardillo Marín, Miguel Ángel de Jorge Turrión, Raquel Vicente Lidón, Luis Bujanda, Patricia Ramírez de la Piscina, Virginia Robles Alonso, Laura Ramos, Raúl Rodríguez Insa, Manuel van Domselaar, David Busquets Casals, Noemí Manceñido Marcos, María Carmen Rodríguez Grau, Edisa María Armesto González, Alfredo J Lucendo, Lucía Márquez-Mosquera, Víctor Manuel Navas López, Vanessa Prieto, Yolanda Ber Nieto, Esther Bernardos Martín, Carlos Castaño Milla, Luis Hernández, Empar Sáinz Arnau, Miquel Sans, Belén Herreros Martínez, Víctor Jair Morales, Miguel Mínguez, Manuel Barreiro-de Acosta, Diana Acosta, Yanire Brenes, Sandra Hermida, Pablo Parra, Ana Garre, Javier P. Gisbert
Publikováno v:
Gastroenterología y Hepatología. 46:S27
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e6218bd5ea4909dbd5263b08ae827142
https://doi.org/10.1016/s0210-5705(23)00127-9
https://doi.org/10.1016/s0210-5705(23)00127-9
Autor:
Iván Guerra, Francisco Barros, María Chaparro, José M. Benítez, María Dolores Martín Arranz, Ruth de Francisco, Marta Piqueras, Luisa de Castro, Ana Y. Carbajo, Fernando Bermejo, Miguel Mínguez, Ana Gutiérrez, Francisco Mesonero, Fiorella Cañete, Carlos González-Muñoza, Marta Calvo, Beatriz Sicilia, Erika Alfambra, Carlos A. Tardillo, Montserrat Rivero, Alfredo J. Lucendo, Luis Bujanda, Manuel van Domselaar, Pedro Almela, Laura Ramos, María Fernández Sánchez, Esther Hinojosa, Cristina Verdejo, Anna Gimenez, Iago Rodríguez-Lago, Noemí Manceñido, José L. Pérez Calle, Mónica del Pilar Moreno, Pedro Genaro Delgado- Guillena, Beatriz Antolín, Patricia Ramírez de la Piscina, M.J. Casanova, Pilar Soto Escribano, Eduardo Martín Arranz, Isabel Pérez Martínez, Raquel Mena, Natalia García Morales, Alicia Granja, Marta Maia Bosca Watts, Rubén Francés, Cristina Fernández, Margalida Calafat, Cristina Roig-Ramos, María Isabel Vera Mendoza, Ángel Carracedo, Eugeni Domènech, Javier P. Gisbert
Publikováno v:
Gastroenterología y Hepatología. 46:S81
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::691cc021a01d41afb6812899c71575e9
https://doi.org/10.1016/s0210-5705(23)00181-4
https://doi.org/10.1016/s0210-5705(23)00181-4